Work from our and the Martinez-Chantarlaboratories have demonstrated that dysregulation of CNNM4 expressionin various models of liver disease, including NASH and AILI, resultsin changes in cellular levels of free Mg2+. This evidence concerns the gene CNNM4 and metabolic dysfunction-associated steatohepatitis.